COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,140 Articles (22,693 medRxiv, 8,447 bioRxiv)

Most recent first Previous |  Page 1262: Articles 12611-12620  | Next

Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape
Rochman, N. D., Faure, G., Wolf, Y. I., Freddolino, P., Zhang, F., Koonin, E. V.
10.1101/2021.08.30.458225 — Posted: 2021-08-31
Inferring Transmission Fitness Advantage of SARS-CoV-2 Variants of Concern in Wastewater Using Digital PCR
Caduff, L., Dreifuss, D., Schindler, T., Devaux, A. J., Ganesanandamoorthy, P., Kull, A., Stachler, E., Fernandez-Cassi, X., Beerenwinkel, N., Kohn, T., Ort, C., Julian, T. R.
10.1101/2021.08.22.21262024 — Posted: 2021-08-31
Short-Term Immune Response After Inactivated SARS-CoV-2 (CoronaVac, Sinovac) And ChAdOx1 nCoV-19 (Vaxzevria, Oxford-AstraZeneca) Vaccinations in Thai Health Care Workers
Jantarabenjakul, W., Chantasrisawad, N., Puthanakit, T., Wacharapluesadee, S., Hirankarn, N., Ruenjaiman, V., Paitoonpong, L., Suwanpimolkul, G., Torvorapanit, P., Pradit, R., Sophonphan, J., PUTCHAROEN, O.
10.1101/2021.08.27.21262721 — Posted: 2021-08-30
Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays
Ma, C., Tan, H., Choza, J., Wang, Y., Wang, J.
10.1101/2021.08.28.458041 — Posted: 2021-08-30
National Excess Mortality from Sub-National data: Method and Application for Argentina
Karlinsky, A.
10.1101/2021.08.30.21262814 — Posted: 2021-08-30
Barrier gesture relaxation during vaccination campaign in France: modelling impact of waning immunity
Vignals, C., Dick, D. W., Thiebaut, R., Wittkop, L., Prague, M., Heffernan, J. M.
10.1101/2021.08.29.21262788 — Posted: 2021-08-30
Localized and Whole-Room Effects of Portable Air Filtration Units on Aerosol Particle Deposition and Concentration in a Classroom Environment
Kong, M., Li, L., Eilts, S., Li, L., Hogan, C. J., Pope, Z. C.
10.1101/2021.08.22.21262392 — Posted: 2021-08-30
The COVID-19 Pandemic and Mental Health Concerns on Twitter in the United States
Zhang, S., Sun, L., Zhang, D., Li, P., Liu, Y., Anand, A., Xie, Z., Li, D.
10.1101/2021.08.23.21262489 — Posted: 2021-08-30
Waning immunity of the BNT162b2 vaccine: A nationwide study from Israel
Goldberg, Y., Mandel, M., Bar-On, Y. M., Bodenheimer, O., Freedman, L. S., Haas, E., Milo, R., Alroy-Preis, S., Ash, N., Huppert, A.
10.1101/2021.08.24.21262423 — Posted: 2021-08-30 Discussion: Onsite
Analysis of alternative Covid-19 mitigation measures in school classrooms: an agent-based model of SARS-CoV-2 transmission
Woodhouse, M. J., Aspinall, W. P., Sparks, S. R., CoMMinS prject "COVID-19 Mapping and Mitigation in Schools"
10.1101/2021.08.30.21262826 — Posted: 2021-08-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).